Neural retinal regeneration with pluripotent stem cells

Cell-Based Therapy for Retinal Degenerative Disease

Volumn 53, Issue , 2014, Pages 97-110

  Ramsden, Conor M ^a,b   Powner, Michael B ^a   Carr, Amanda Jayne F ^a   Smart, Matthew J K ^a   Da Cruz, Lyndon ^a,b   Coffey, Peter J ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925875292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000357363     Document Type: Chapter

References (72)

1. Jager RD, Mieler WF, Miller JW: Agerelated macular degeneration. N Engl J Med 2008; 358: 2606-2617.
2. de Jong PTVM: Age-related macular degeneration. N Engl J Med 2006; 355: 1474-1485.
3. Walia S, Fishman GA: Natural history of phenotypic changes in Stargardt macular dystrophy. Ophthalmic Genet 2009; 30: 63-68.
4. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, et al: A photoreceptor cell-specific ATPbinding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997; 15: 236-246.
5. Hartong DT, Berson EL, Dryja TP: Retinitis pigmentosa. Lancet 2006; 368: 1795-1809.
6. Baglio SR, Pegtel DM, Baldini N: Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 2012; 3:359.
7. Ying Q-L, Nichols J, Evans EP, Smith AG: Changing potency by spontaneous fusion. Nature 2002; 416: 545-548.
8. Schwartz SD, Hubschman J-P, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, et al: Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012; 379: 713-720.
9. McGill TJ, Cottam B, Lu B, Wang S, Girman S, Tian C, et al: Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur J Neurosci 2012; 35: 468-477.
10. Lund RD, Wang S, Lu B, Girman S, Holmes T, Sauvé Y, et al: Cells Isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2009; 25: 602-611.
11. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R: Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina 2011; 31: 1207-1214.
12. Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, et al: Long-term effects of intravitreal injection of GMPgrade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2012; 53: 986-994.
13. Kumar A, Raj M, Mochi TB, Mohanty S, Seth T, Azad R: Assessment of central retinal function after autologous bone marrow derived intravitreal stem cells injection in patients with retinitis pigmentosa using multifocal ERG: a pilot study. World J Retin Vitreous 2012; 2: 5-13.
14. Carr A-J, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL, et al: Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009; 4:e8152.
15. Medeiros NE, Curcio CA: Preservation of ganglion cell layer neurons in agerelated macular degeneration. Invest Ophthalmol Vis Sci 2001; 42: 795-803.
16. da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P: RPE transplantation and its role in retinal disease. Prog Retin Eye Res 2007; 26: 598-635.
17. Chen FK, Patel PJ, Uppal GS, Rubin GS, Coffey PJ, Aylward GW, et al: A comparison of macular translocation with patch graft in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009; 50: 1848-1855.
18. Bao ZZ, Cepko CL: The expression and function of Notch pathway genes in the developing rat eye. J Neurosci 1997; 17: 1425-1434.
19. Jadhav AP, Roesch K, Cepko CL: Development and neurogenic potential of Müller glial cells in the vertebrate retina. Progr Retin Eye Res 2009; 28: 249-262.
20. Chiang C, Litingtung Y, Lee E, Young KE, Corden JL, Westphal H, et al: Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996; 383: 407-413.
21. Fuhrmann S: Wnt signaling in eye organogenesis. Organogenesis 2008; 4: 60-67.
22. Tripathi BJ, Tripathi RC, Livingston AM, Borisuth NS: The role of growth factors in the embryogenesis and differentiation of the eye. Am J Anat 1991; 192: 442-471.
23. Zhang SS-M, Fu X-Y, Barnstable CJ: Molecular aspects of vertebrate retinal development. Mol Neurobiol 2002; 26: 137-152.
24. Hausman RE: Ocular extracellular matrices in development. Prog Retin Eye Res 2007; 26: 162-188.
25. O'Brien KMB, Schulte D, Hendrickson AE: Expression of photoreceptor-associated molecules during human fetal eye development. Mol Vis 2003; 9: 401-409.
26. Tansley K: The development of the rat eye in graft. J Exp Biol 1946; 22: 221-224.
27. Royo PE, Quay WB: Retinal transplantation from fetal to maternal mammalian eye. Growth 1959; 23: 313-336.
28. Seiler MJ, Aramant RB: Cell replacement and visual restoration by retinal sheet transplants. Prog Retin Eye Res 2012; 31: 661-687.
29. MacLaren RE, Pearson RA, MacNeil A, Douglas RH, Salt TE, Akimoto M, et al: Retinal repair by transplantation of photoreceptor precursors. Nature 2006; 444: 203-207.
30. Pearson RA, Barber AC, Rizzi M, Hippert C, Xue T, West EL, et al: Restoration of vision after transplantation of photoreceptors. Nature 2012; 485: 99-103.
31. Gust J, Reh TA: Adult donor rod photoreceptors integrate into the mature mouse retina. Invest Ophthalmol Vis Sci 2011; 52: 5266-5272.
32. Humayun MS, de Juan E, del Cerro M, Dagnelie G, Radner W, Sadda SR, et al: Human neural retinal transplantation. Invest Ophthalmol Vis Sci 2000; 41: 3100-3106.
33. Das T, del Cerro M, Jalali S, Rao VS, Gullapalli VK, Little C, et al: The transplantation of human fetal neuroretinal cells in advanced retinitis pigmentosa patients: results of a long-term safety study. Exp Neurol 1999; 157: 58-68.
34. Klassen HJ, Ng TF, Kurimoto Y, Kirov I, Shatos M, Coffey P, et al: Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci 2004; 45: 4167-4173.
35. Thomson JA: Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
36. Singhal S, Bhatia B, Jayaram H, Becker S, Jones MF, Cottrill PB, et al: Human Muller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. Stem Cells Transl Med 2012; 1: 188-199.
37. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
38. Ying Q-L, Smith AG: Defined conditions for neural commitment and differentiation. Meth Enzymol 2003; 365: 327-341.
39. Ikeda H, Osakada F, Watanabe K, Mizuseki K, Haraguchi T, Miyoshi H, et al: Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci USA 2005; 102: 11331-11336.
40. Osakada F, Ikeda H, Mandai M, Wataya T, Watanabe K, Yoshimura N, et al: Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26: 215-224.
41. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, et al: Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126-131.
42. Pera EM, Wessely O, Li SY, De Robertis EM: Neural and head induction by insulin-like growth factor signals. Dev Cell 2001; 1: 655-665.
43. Lamba DA, Karl MO, Ware CB, Reh TA: Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 12769-12774.
44. Lamba DA, Gust J, Reh TA: Transplantation of human embryonic stem cellderived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 2009; 4: 73-79.
45. Banin E, Obolensky A, Idelson M, Hemo I, Reinhardtz E, Pikarsky E, et al: Retinal incorporation and differentiation of neural precursors derived from human embryonic stem cells. Stem Cells 2006; 24: 246-257.
46. Parameswaran S, Balasubramanian S, Babai N, Qiu F, Eudy JD, Thoreson WB, et al: Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells 2010; 28: 695-703.
47. Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL, et al: Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009; 106: 16698-16703.
48. Meyer JS, Howden SE, Wallace KA, Verhoeven AD, Wright LS, Capowski EE, et al: Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 2011; 29: 1206-1218.
49. Phillips MJ, Wallace KA, Dickerson SJ, Miller MJ, Verhoeven AD, Martin JM, et al: Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci 2012; 53: 2007-2019.
50. Tucker BA, Park I-H, Qi SD, Klassen HJ, Jiang C, Yao J, et al: Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One 2011; 6:e18992.
51. Hambright D, Park K-Y, Brooks M, McKay R, Swaroop A, Nasonkin I: Longterm survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina. Mol Vis 2012; 18:920.
52. Mellough CB, Sernagor E, Moreno-Gimeno I, Steel DHW, Lako M: Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells 2012; 30: 673-686.
53. Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S, et al: Selforganizing optic-cup morphogenesis in three-dimensional culture. Nature 2011; 472: 51-56.
54. Eiraku M, Sasai Y: Mouse embryonic stem cell culture for generation of threedimensional retinal and cortical tissues. Nat Protoc 2012; 7: 69-79.
55. Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K, et al: Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012; 10: 771-785.
56. Garita-Hernández M, Diaz-Corrales F, Lukovic D, Guede IG, Lloret AD, Sánchez MLV, et al: Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro. Stem Cells 2013; 31: 966-978.
57. Boucherie C, Mukherjee S, Henckaerts E, Thrasher AJ, Sowden JC, Ali RR: Brief report: self-organizing neuroepithelium from human pluripotent stem cells facilitates derivation of photoreceptors. Stem Cells 2013; 31: 408-414.
58. Ramsden CM, Powner MB, Carr A-JF, Smart MJK, da Cruz L, Coffey PJ: Stem cells in retinal regeneration: past, present and future. Development 2013; 140: 2576-2585.
59. Jin Z-B, Okamoto S, Osakada F, Homma K, Assawachananont J, Hirami Y, et al: Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 2011; 6:e17084.
60. Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U: Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 2004; 45: 4251-4255.
61. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA: Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res 2005; 80: 235-248.
62. Vugler A, Carr A-J, Lawrence J, Chen LL, Burrell K, Wright A, et al: Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 2008; 214: 347-361.
63. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M: Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 348-362.
64. Warren L, Manos PD, Ahfeldt T, Loh Y-H, Li H, Lau F, et al: Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-630.
65. Kim D, Kim C-H, Moon J-I, Chung Y-G, Chang M-Y, Han B-S, et al: Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472-476.
66. Osakada F, Jin Z-B, Hirami Y, Ikeda H, Danjyo T, Watanabe K, et al: In vitro differentiation of retinal cells from human pluripotent stem cells by smallmolecule induction. J Cell Sci 2009; 122: 3169-3179.
67. Zhao T, Zhang Z-N, Rong Z, Xu Y: Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-215.
68. Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS: Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013; 12: 407-412.
69. Zimmermann A, Preynat-Seauve O, Tiercy J-M, Krause K-H, Villard J: Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. Stem Cells Dev 2012; 21: 2364-2373.
70. Bottenstein JE, Skaper SD, Varon SS, Sato GH: Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium. Exp Cell Res 1980; 125: 183-190.
71. Brewer GJ, Torricelli JR, Evege EK, Price PJ: Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 1993; 35: 567-576.
72. Phillips MJ, Otteson DC, Sherry DM: Progression of neuronal and synaptic remodeling in the rd10 mouse model of retinitis pigmentosa. J Comp Neurol 2010; 518: 2071-2089.